triazoles has been researched along with u-50488 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Graziani, M; Nencini, P; Valeri, P | 1 |
| Blough, BE; Freeman, KB; Pareek, T; Prisinzano, TE; Schrock, HM; Sufka, KJ; Zamarripa, CA | 1 |
2 other study(ies) available for triazoles and u-50488
| Article | Year |
|---|---|
Dapiprazol prevents U50,488H-mediated suppression of preparatory components of drinking behavior in rats.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Adrenergic alpha-Antagonists; Animals; Body Weight; Depression, Chemical; Diuresis; Drinking Behavior; Male; Naloxone; Piperazines; Pyrrolidines; Rats; Rats, Inbred Strains; Triazoles | 1991 |
The kappa-opioid receptor agonist, triazole 1.1, reduces oxycodone self-administration and enhances oxycodone-induced thermal antinociception in male rats.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Opioid; Animals; Dose-Response Relationship, Drug; Male; Nociception; Oxycodone; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Receptors, Opioid, mu; Self Administration; Triazoles | 2021 |